SOD1 and amyotrophic lateral sclerosis: Importantly, this effect was blocked by C4F6 (Bosco et al., 2010), indicating that C4F6 reports on the toxic region within SOD1 and therefore may be useful for designing immunotherapeutic strategies for humans with ALS.